Ken Griffin Vor Biopharma Inc. Put Options Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024
BUY
$1.8 - $2.85 $180 - $285
100 New
100 $0
Q3 2023

Nov 14, 2023
SELL
$2.1 - $3.35 $2,100 - $3,350
-1,000 Reduced 22.73%
3,400 $7,000
Q2 2023

Aug 14, 2023
BUY
$3.09 - $5.33 $9,888 - $17,056
3,200 Added 266.67%
4,400 $13,000
Q1 2023

May 15, 2023
SELL
$4.68 - $6.96 $468 - $696
-100 Reduced 7.69%
1,200 $6,000
Q4 2022

Feb 14, 2023
BUY
$3.77 - $7.43 $4,901 - $9,659
1,300 New
1,300 $8,000

Others Institutions Holding VOR

# of Institutions
73
Shares Held
47.9M
Call Options Held
1.5K
Put Options Held
0
View Full List

About Vor Biopharma Inc.

VOR Quotes by TradingView
  • Ticker VOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,056,300
  • Market Cap $25.1M
  • Description
  • Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...
More about VOR
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email